NEW YORK (GenomeWeb) – WaferGen Bio-systems reported after the close of the market Tuesday that its third quarter revenues rose 20 percent, driven by a 62 percent increase in SmartChip system sales. The results were in line with preliminary revenues released last month.

For the three months ended Sept. 30, WaferGen reported total revenues of $2.4 million compared to $2.0 million in Q3 2015.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.